Nano structured microemulsion and co-crystallization of lactic acid and salicylic acid as topical drug

Thumbnail Image
Aljamal, Maher
Journal Title
Journal ISSN
Volume Title
This study aims to prepare topical salicylic acid and lactic acid microemulsion with a different formulation applied using the minimum amount of Tweens. The sugar surfactant used in this study is sorbitan monooleate (Tween 80). Short chain alcohol used as a co-surfactant which is propylene glycol. The oil phase used is castor oil. The aqueous phase is purified water. Also this study aims to prepare a co-crystal paradigm between salicylic acid and lactic acid as the active pharmaceutical ingredients, in presence of using different co-solvents. In this research, we studied the effect of different percentage of surfactants on the phase behavior of the systems suggested at different temperatures 25, 37 and 45°C. We also explored the effect of adding co-surfactant (propylene glycol) on the phase behavior. The addition of propylene glycol as a co-surfactant contributes clearly in forming much smallest and stable micro emulsion droplet size besides giving pliability to the infected skin. Lastly the phase behavior of sorbitan monooleate was studied as a function of temperature and surfactant concentration; that is presented in the form of the well known phase diagram that shows an isotropy microemulsion solution (using visual inspection, cross polarizer and dynamic light scattering) as low as 4% water addition at all temperatures (25˚C, 37˚C and 45˚C). Also in this research, we studied the ability of different co-solvents used in the formation of co-crystal paradigms, such as ethanol (96%), methanol (99%), diethyl ether and acetonitrile either in reflux or grinding techniques. The co-crystal paradigm was obtained in all reflux techniques applied successfully; more than 80% from the grinding technique of the samples obtained creates a merged compound successfully. All paradigms are tested using Fourier Transform Infra- Red spectroscopy (FTIR) and the melting point range is tested for part of them. The co-crystals obtained were tested for solubility modifications and the results show a clear change in their solubility to be sparingly soluble to soluble in water. Also the co-crystal solids were tested for their melting point and the variation change observed is dependent on the target active pharmaceutical concentration and depending on the molar ratio for each co-crystal tested. But even so the melting point was changed to be lower than pure salicylic acid melting point and higher than lactic acid.